Avantor, Inc. announced that Benoit Gourdier will join the company as EVP, Biopharma Production on October 2, 2023. Mr. Gourdier will succeed Dr. Ger Brophy, who will retire from the company on February 29, 2024. Following his retirement, Dr. Brophy will continue to serve as an advisor to the company as well as Chair of the Avantor Scientific Advisory Board.

Mr. Gourdier joins Avantor with more than 25 years in the life sciences industry, with a track record of driving growth and leading global commercial organizations. He joins the company from Millipore Sigma, where he most recently served as Senior Vice President and General Manager, BioReliance Contract Testing Services. Previously, he was Vice President and Head of Bioprocessing within Merck KGaA, Darmstadt, Germany, and held accountability for the Asia Pacific region.

Benoit started his career at Millipore where he held various roles in field marketing and sales. He attended Polytech Clermont in France where he earned a master's degree in biotechnology engineering. Dr. Brophy joined Avantor in 2018.

His contributions include expanding Avantor's bioproduction capabilities and geographic footprint, leading development of products and solutions to support new biologic platforms and establishing innovation centers to facilitate customer collaboration around the world.